Summary
The National Institutes of Health (NIH) is soliciting research applications under Program Announcement PAR-25-325 to integrate biospecimen science approaches into clinical assay development. This is a U01 cooperative research grant mechanism, explicitly excluding clinical trials. The opportunity is open for a multi-year window from December 2024 through September 2027, indicating a rolling or multiple-cycle submission structure. The focus is on advancing the scientific rigor and translational utility of clinical assays by incorporating biospecimen science methodologies.